Evidence map›Paper›PMID 38302337›Full record

ArticleVaccine2024

Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public-private partnership with pharmacies.

Nkenge Jones-Jack, Roua El Kalach, Diana Yassanye, Ruth Link-Gelles, Abdulhakeem Olorukooba, Amee Khamar deMartino, Mattie Elam, Doug Romerhausen, Marley Vazquez, Chris Duggar and 6 more

Abstract read
In one paragraph

Article in Vaccine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nkenge Jones-JackCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: ncj9@cdc.gov.
Roua El KalachCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Diana YassanyeCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Ruth Link-GellesCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Abdulhakeem OlorukoobaCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Amee Khamar deMartinoCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Chickasaw Health Consulting, LLC, Norman, OK, United States.
Mattie ElamCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Goldbelt Professional Services, LLC, Chesapeake, VA, United States.
Doug RomerhausenCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Goldbelt Professional Services, LLC, Chesapeake, VA, United States.
Marley VazquezCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Chris DuggarCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Christine KimCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Anita PatelCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Angela GuoCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Radhika GharpureCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Ashley TippinsCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Lori MooreCOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

To support efforts to vaccinate millions of Americans across the United States (US) against COVID-19, the US federal government (USG) launched the Pharmacy Partnership for Long-Term Care Program (PPP) in December 2020 and the Federal Retail Pharmacy Program (FRPP) in February 2021. These programs consisted of a collaborative partnership with the USG and 21 pharmacy organizations, including large retail chains, coordinating pharmacy services administrative organizations (PSAOs) representing independent retail and long-term care pharmacies, and pharmacy network administrators. These pharmacy organizations represented over 46,000 providers and created a robust channel for far-reaching COVID-19 vaccination across 56 state and local jurisdictions. PPP reported more than 8 million COVID-19 doses administered to residents and staff in long-term care facilities (LTCFs) as of June 2021. In addition, FRPP was responsible for administering more than 304 million doses, accounting for approximately 49% of all COVID-19 doses administered as of June 2023. This unprecedented public-private partnership allowed USG to rapidly adapt, expand, and aim to provide equitable access to vaccines for adults and eligible-aged children during the COVID-19 pandemic. As the largest federal COVID-19 vaccination program, the FRPP exemplifies how public-private partnerships can expand access to immunizations during a public health emergency. End-to-end informatics support helped pharmacies meet critical national public health goals and served as convenient access points for sustained health services. This manuscript describes lessons learned regarding informatics coordination with participating pharmacy partners to support the rapid and safe administration of COVID-19 vaccines across the US. The processes of onboarding to CDC's complex data network, establishing connections to state and local immunization information systems (IIS), and monitoring the quality of data pharmacy partners submitted to the CDC Data Clearinghouse (DCH) in alignment with the COVID-19 Vaccine Reporting Specifications (CVRS) are highlighted.

Indexed as

COVID-19COVID-19 VaccinesPharmaciesPublic-Private Sector PartnershipsHumansImmunization ProgramsPandemicsPublic Health InformaticsSARS-CoV-2United StatesVaccinationCOVID-19 VaccinesCOVID-19ImmunizationInformaticsLong-term care facilitiesPartnershipsPharmacyPharmacy management systemsPublic health surveillanceVaccine administration

Identifiers

PMID38302337
PMCPMC11932155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.